Advertisement

Brain Vein Compound Successful on Pigs

If it works in pigs, it’ll work in people.

That sums up Micro Therapeutics Inc.'s plans to expand testing of its experimental treatment for a brain ailment this year.

The San Clemente-based maker of medical devices aims to one day sell its plastic Embolyx device to treat patients with a brain disorder characterized by excessive proliferation of veins. In a recent test, the compound, injected into the neck veins of 18 pigs, successfully blocked off the veins--a result the company now hopes to achieve in tests on people.

In one study, a UCLA researcher aims to test the treatment in 10 patients--and the study could begin shortly if the university approves it. Separately, Micro Therapeutics plans its own broader study involving more patients at half a dozen centers.

Advertisement

*

Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at barbara.marsh@latimes.com.


Advertisement